Review
Open access
Jul 2026
Current status and targeted therapies in endometrial cancer: Molecular classification-driven treatment strategies (Review)
Key oncogenic signaling pathways, including PI3K/AKT/mTOR and RAS/RAF/MEK/ERK, were discussed in the context of therapeutic targeting and precision medicine and emerging strategies, particularly immunotherapy and combination approaches were addressed.
Xinyu Li, Jie Liu, Fang-Fang Huang et al.
· Oncology Letters · 0 citations